Abstract
There is lack of information on the histological characteristics of the intestinal mucosa in Bangladeshi children, which is considered to be the traditional gold standard for diagnosis of environmental enteric dysfunction (EED). The purpose of the study was to evaluate the intestinal histological characteristics of stunted children aged between 12-18 months with possible EED. 110 children with chronic malnutrition (52 stunted with length-for-age Z score, LAZ<-2 and 58 at risk of stunting with LAZ <-1 to -2) from the Bangladesh Environmental Enteric Dysfunction (BEED) study protocol who underwent upper gastrointestinal (GI) endoscopy were selected for this study. To explore the association of EED with childhood stunting, upper GI endoscopy was done and the biopsy specimens were studied for histopathology. Villous height and crypt depth were measured and the presence and intensity of inflammatory infiltrates in the lamina propria was investigated. Bivariate analysis was performed to examine the relationship between stunting and histologic morphology. More than 90% children irrespective of nutritional status were diagnosed to have chronic non-specific duodenitis on histopathology. Half of the children from both groups had villous atrophy as well as crypt hyperplasia and lymphocytic infiltration was present in more than 90% children, irrespective of groups. However, no statistically significant difference was observed when compared between the groups. The prevalence of chronic non-specific duodenitis in Bangladeshi children, irrespective of nutritional status, was high. A significant number of these children had abnormal findings in intestinal histomorphology.
Author Summary EED or environmental enteropathy, results in poor gut health and suboptimal child growth, and is considered to play a major role on childhood stunting in the tropics. Growth faltering due to decreased nutrient absorption as a result of alteration of small intestinal histological structure manifested as blunting or atrophy of intestinal villi, hyperplasia or elongation of crypts and infiltration of inflammatory cells in the lamina propria, has been demonstrated as the basic characteristics of EED. The traditional gold standard for the diagnosis of EED is intestinal biopsy and assessment of the histomorphological alterations. There is lack of information on the histological characteristics of the intestinal mucosa in Bangladeshi children. The purpose of the study was to evaluate the intestinal histological characteristics of stunted children aged between 12-18 months with possible EED. 110 children with chronic malnutrition who underwent upper gastrointestinal (GI) endoscopy were selected for this study and the biopsy specimens were studied for histopathology. Villous height and crypt depth were measured and the presence and intensity of inflammatory infiltrates in the lamina propria was investigated. More than 90% children irrespective of nutritional status were diagnosed to have chronic non-specific duodenitis. Half of the children from both groups had villous atrophy as well as crypt hyperplasia and lymphocytic infiltration was present in more than 90% children, irrespective of groups. However, no statistically significant difference was observed when compared between the groups.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov ID: NCT02812615 (https://clinicaltrials.gov/ct2/results?cond=NCT02812615&term=&cntry=&state=&city=&dist=) Date of first registration: 24/06/2016
Clinical Protocols
https://clinicaltrials.gov/ct2/results?cond=NCT02812615&term=&cntry=&state=&city=&dist=
Funding Statement
This work was supported by the Bill & Melinda Gates Foundation [OPP1136751] and was funded by the Bill and Melinda Gates Foundation (BMGF) under its Global Health Program. The project investment ID is OPP1136751 (https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2015/11/OPP1136751). TA received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was taken from Institutional review committee of icddr,b. The protocol number is PR-16007. A written informed consent for the intervention as well as the upper GI endoscopy and biopsy was obtained from the parents of children after explaining the aims and procedures of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying the results presented in the study are available from the corresponding author on reasonable request upon acceptance.
